Design, Synthesis and Biological Evaluation of Novel 4-Substituted Coumarin Derivatives as Antitumor Agents
Herein, fifteen new compounds containing coumarin, 1,2,3-triazole and benzoyl- substituted arylamine moieties were designed, synthesized and tested in vitro for their anticancer activity. The results showed that all tested compounds had moderate antiproliferative activity against MDA-MB-231, a human...
Main Authors: | Ran An, Zhuang Hou, Jian-Teng Li, Hao-Nan Yu, Yan-Hua Mou, Chun Guo |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-09-01
|
Series: | Molecules |
Subjects: | |
Online Access: | http://www.mdpi.com/1420-3049/23/9/2281 |
Similar Items
-
Novel 1,2,3-Triazole-Coumarin Hybrid Glycosides and Their Tetrazolyl Analogues: Design, Anticancer Evaluation and Molecular Docking Targeting EGFR, VEGFR-2 and CDK-2
by: Wael A. El-Sayed, et al.
Published: (2022-03-01) -
New 1,2,3-Triazole-Coumarin-Glycoside Hybrids and Their 1,2,4-Triazolyl Thioglycoside Analogs Targeting Mitochondria Apoptotic Pathway: Synthesis, Anticancer Activity and Docking Simulation
by: Wael A. El-Sayed, et al.
Published: (2022-09-01) -
Synthesis, molecular modeling and anticancer activity of new coumarin containing compounds
by: Shaimaa A. Morsy, et al.
Published: (2017-09-01) -
Synthesis and biological evaluation of novel 7-hydroxy-4-phenylchromen-2-one–linked to triazole moieties as potent cytotoxic agents
by: Chuan-Feng Liu, et al.
Published: (2017-01-01) -
Design, Synthesis, and Mechanism of Dihydroartemisinin–Coumarin Hybrids as Potential Anti-Neuroinflammatory Agents
by: Haonan Yu, et al.
Published: (2019-04-01)